- Home
- NBTX vs SRV Comparison
NBTX vs SRV Comparison
Compare NBTX & SRV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBTX
- SRV
- Stock Information
- Founded
- NBTX 2003
- SRV 2007
- Country
- NBTX France
- SRV United States
- Employees
- NBTX N/A
- SRV N/A
- Industry
- NBTX Biotechnology: Pharmaceutical Preparations
- SRV Finance Companies
- Sector
- NBTX Health Care
- SRV Finance
- Exchange
- NBTX Nasdaq
- SRV Nasdaq
- Market Cap
- NBTX 167.8M
- SRV 178.7M
- IPO Year
- NBTX 2020
- SRV N/A
- Fundamental
- Price
- NBTX $4.48
- SRV $41.81
- Analyst Decision
- NBTX Strong Buy
- SRV
- Analyst Count
- NBTX 1
- SRV 0
- Target Price
- NBTX $8.00
- SRV N/A
- AVG Volume (30 Days)
- NBTX 9.0K
- SRV 33.9K
- Earning Date
- NBTX 04-02-2025
- SRV 01-01-0001
- Dividend Yield
- NBTX N/A
- SRV 13.38%
- EPS Growth
- NBTX N/A
- SRV N/A
- EPS
- NBTX N/A
- SRV N/A
- Revenue
- NBTX N/A
- SRV N/A
- Revenue This Year
- NBTX N/A
- SRV N/A
- Revenue Next Year
- NBTX $221.06
- SRV N/A
- P/E Ratio
- NBTX N/A
- SRV N/A
- Revenue Growth
- NBTX N/A
- SRV N/A
- 52 Week Low
- NBTX $2.76
- SRV $30.73
- 52 Week High
- NBTX $6.00
- SRV $44.30
- Technical
- Relative Strength Index (RSI)
- NBTX 51.68
- SRV 55.07
- Support Level
- NBTX $4.18
- SRV $41.50
- Resistance Level
- NBTX $5.76
- SRV $42.77
- Average True Range (ATR)
- NBTX 0.24
- SRV 0.59
- MACD
- NBTX -0.06
- SRV 0.01
- Stochastic Oscillator
- NBTX 21.69
- SRV 61.01
About NBTX Nanobiotix S.A.
Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.
About SRV NXG Cushing Midstream Energy Fund of Beneficial Interest
NXG Cushing Midstream Energy Fund is a non-diversified, closed-end management investment company with an investment objective of seeking a high after-tax total return from a combination of capital appreciation and current income. The fund invests at least 80% of its net assets, plus any borrowings for investment purposes, in midstream energy investments.